Parliamentary Friends of Arthritis event
Discover more...
-
Arthritis Australia’s first interactive Parliamentary Summit on Better Care for Arthritis and Musculoskeletal Conditions
Arthritis Australia’s first interactive Parliamentary Summit on Better Care for Arthritis and Musculoskeletal Conditions on 22 August was attended by over 90 consumers, clinicians, researchers,...
-
Arthritis Australia welcomes funding for kids with arthritis
Arthritis Australia has welcomed Australian Government funding announced in the federal budget for kids living with juvenile arthritis, including renewed funding for Arthritis Australia and...
-
Shortage of Abatacept (Orencia®) Resolved – update
Update: August 28, 2024. Bristol Myers Squibb (BMS), the manufacturer of Orencia (abatacept), has announced that the shortage of subcutaneous abatacept will be resolved as...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox: